Skyhawk Therapeutics
Peter Lento, CPA has been in the accounting industry since 2011. Peter began their career at PricewaterhouseCoopers as an Assurance Associate. In 2012, they moved to CRR, LLP as a Senior Accountant. In 2016, they became Controller at Pharmaceutical Strategies. In 2019, they held both the roles of Assistant Controller and Accounting Manager at both Dragonfly Therapeutics, Inc. and Skyhawk Therapeutics.
Peter Lento, CPA obtained their Bachelor of Science in Accounting from the Isenberg School of Management at UMass Amherst in 2010. Peter then went on to pursue a Master of Science in Accounting from the same institution, graduating in 2011. Peter is also a Certified Public Accountant.
This person is not in the org chart
This person is not in any offices
Skyhawk Therapeutics
1 followers
At Skyhawk Therapeutics we invent small molecules using proprietary kinetic, structural and computational models that correct RNA splicing and mis-spicing. Our small molecule platform accelerates drug development across a broad range of disease types.